Harish Dave

Harish Dave

Company: AUM Biosciences

Job title: Chief Medical Officer


Co-Targeting PIM Kinase and PI3K/mTOR- A Promising Treatment Strategy by AUM302 10:05 am

• Delve into the main reasons for exploring combination therapies in targeting the PI3K Pathway i.e., reducing toxicity, overcoming resistance mechanisms, and improving potency of PI3K inhibitors • Gain key insights into what combination therapies show promise • Investigate the challenges and setbacks in developing successful combination therapiesRead more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.